Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of GSK 2189242A Pneumococcal Vaccine in Infants
NCT01204658Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2010
- Primary completion
- Nov 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
A Phase 2 trial of GSK 2189242A in pneumococcal infection, sponsored by GSK. Started Sep 2010; status: completed.
02
Drugs
GSK 2189242A
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT01204658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01204658.